- new targeted therapies for breast cancer
- personalised therapies for breast cancer
Professor Nicholas Turner is a Consultant Medical Oncologist who specialises in the treatment of breast cancer. Dr Turner read Natural Sciences at Cambridge University before qualifying in 1997 from the University of Oxford Medical School.
After completing general medical training in London, he trained in medical oncology at Royal Free and University College Hospitals and completed a PhD at The Institute of Cancer Research in 2006. He joined the Breast Unit of The Royal Marsden as a Consultant in Medical Oncology in 2008.
He is a Team Leader in Molecular Oncology at the Breast Cancer Now Research Centre at the Institute of Cancer Research (ICR). He is Breast Theme Lead for The Royal Marsden NIHR Biomedical Research Centre, and a member of the NCRI Breast Cancer Clinical Studies Group.
He is the Breast Domain Lead of the Genomics England Clinical Interpretation Partnerships. He sits on the organising committees of many international conferences on breast cancer, was the executive chair of the IMPAKT 2015 breast cancer conference, and is a scientific editor of the journal Cancer Discovery.
Professor Turner is Chief Investigator of a number of national and international trials of precision therapy in breast cancer. His research interests include the development of new therapies for breast cancer and using liquid biopsies to deliver more precise treatment for breast cancer.
In 2017 he was awarded the title of Professor by the ICR.